Medicis Pharmaceutical Corp (MRX) Tops Q1 EPS by 1c; Issues Outlook
Tweet Send to a Friend
Medicis Pharmaceutical Corp (NYSE: MRX) reported Q1 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
